Your search returned 3 results.

Results
	1.	Efficacy and safety of atazanavir, with or without ritonavir, as part of once-daily highly active antiretroviral therapy regimens in antiretroviral-naive patients. [electronic resource] by Malan, D R Krantz, Edrich David, Neal Wirtz, Victoria Hammond, Janet McGrath, Donnie Producer: 20080318 In: Journal of acquired immune deficiency syndromes (1999) vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	96-week efficacy and safety of atazanavir, with and without ritonavir, in a HAART regimen in treatment-naive patients. [electronic resource] by Malan, D R Niel Krantz, Edrich David, Neal Mathew, Marina Iloeje, Uchenna H McGrath, Donnie Producer: 20110517 In: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. [electronic resource] by van Leth, F Phanuphak, P Ruxrungtham, K Baraldi, E Miller, S Gazzard, B Cahn, P Lalloo, U G van der Westhuizen, I P Malan, D R Johnson, M A Santos, B R Mulcahy, F Wood, R Levi, G C Reboredo, G Squires, K Cassetti, I Petit, D Raffi, F Katlama, C Murphy, R L Horban, A Dam, J P Hassink, E van Leeuwen, R Robinson, P Wit, F W Lange, J M A Producer: 20040510 In: Lancet (London, England) vol. 363 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)